In addition, patients with high AGP levels also had lower vascular intervention-free survival rates [mild (76% vs. 100%, p = 0.01), moderate (83% vs. 97%, p = 0.02), severe (71% vs. 96%, p = 0.02), all PAD (78% vs. 97%)], and amputation-free survival [all PAD (91% vs. 99%)]. Here, ATP5MK is linked to peripheral arterial disease.